Induction of transplantation tolerance with a short course of tacrolimus (FK506)

Transplantation

Volumn 71, Issue 10, 2001, Pages 1368-1379

  Utsugi, Ryu ^a   Barth, Rolf N ^a   Lee, Richard S ^a   Kitamura, Hiroshi ^a   LaMattina, John C ^a   Ambroz, Joseph ^a   HSachs, David ^a   Yamada, Kazuhiko ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; MAJOR HISTOCOMPATIBILITY ANTIGEN; TACROLIMUS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MEDIATED CYTOTOXICITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; HAPLOTYPE; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY DONOR; KIDNEY FUNCTION; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; SWINE;

EID: 0035958117     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200105270-00003     Document Type: Article

References (51)

1. Cyclosporine: A revolution in transplantation
2. FK 506 in solid organ transplantation
3. A long-term comparison of tacrolimus (FK506) versus cyclosporine in liver transplantation: A report of the United States FK506 Study Group
4. Cyclosporine: A new immunosuppressive agent for organ transplantation
5. A pilot study of immunosuppressive monotherapy in liver transplantation: Tacrolimus versus microemulsified cyclosporin
6. Tacrolimus versus cyclosporin for immunosuppression in renal transplantation: Meta-analysis of randomised trials
7. The role of tacrolimus in adult kidney transplantation: A review
8. Chronic renal allograft failure: Clinical overview
9. Predisposing factors in the development of chronic allograft dysfunction
10. Chronic rejection: An undefined conundrum
11. Induction of specific tolerance to class I disparate renal allografts in miniature swine with cyclosporine
12. Effect of major histocompatibility complex matching on the development of tolerance to primarily vascularized renal allografts: A study in miniature swine
13. Discovery of FK-506, a novel immunosuppressant isolated from Streptomyces tsukubaensis
14. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation
15. Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: A report of the European Tacrolimus Multicenter Renal Study Group
16. Tacrolimus is superior to cyclosporine in liver transplantation
17. Transplantation in miniature swine. I. Fixation of the major histocompatibility complex
18. Mechanism of specific transplantation tolerance induction by vascular allografts across a class I difference in miniature swine
19. Role of the thymus in transplantation tolerance in miniature swine. I. Requirement of the thymus for rapid and stable induction of tolerance to class I-mismatched renal allografts
20. The renal allograft biopsy
21. Transplantation in miniature swine. VII. Evidence for cellular immune mechanisms in hyperacute rejection of renal allografts
22. Immunosuppression of canine, monkey, and baboon allografts by FK506: With special reference to synergism with other drugs and to tolerance induction
23. Effects of combination treatment with FK506 and cyclosporine on survival time and vascular changes in renal-allograft-recipient dogs
24. FK-506 in experimental renal allografts
25. Cardiotoxicity of long-term intravenous administration of FK506 in rabbits: Dose relationship and recovery after discontinuance
26. Conversion from cyclosporin (Neoral) to tacrolimus (Prograf) in renal allograft recipients with chronic graft nephropathy: Results of an observational study
27. Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation
28. Tacrolimus therapy for ABO-incompatible kidney transplantation
29. Successful treatment of steroid-resistant severe acute GVHD with 24-h continuous infusion of FK506
30. Effect of class II antigen matching on renal allograft survival in miniature swine
31. Tolerance to primarily vascularized allografts in miniature swine
32. Mechanism of cyclosporin-induced tolerance to primarily vascularized allografts in miniature swine: Effect of administration of exogenous IL-2
33. Development of tolerance to class II mismatched renal transplants following a short course of cyclosporine therapy in miniature swine
34. Tolerance to class I disparate renal allografts in miniature swine: Maintenance of tolerance despite induction of specific antidonor CTL responses
35. Induction of tolerance to renal allografts across single-haplotype MHC disparities in miniature swine
36. Effect of cyclosporin A on murine and human T helper cell clones
37. + T cell helper function is particularly sensitive to cyclosporine suppression in vivo
38. Tolerance to primarily vascularized allografts in miniature swine
39. Class II genes of miniature swine. II. Molecular identification and characterization of beta genes from the SLAc haplotype
40. Class II genes of miniature swine. III. Characterization of an expressed pig class II gene homologous to HLA-DQA
41. Class II genes of miniature swine. IV. Characterization and expression of two allelic class II DQB cDNA clones
42. Structure of miniature swine class II DRB genes: Conservation of hypervariable amino acid residues between distantly related mammalian species
43. Structure and expression of class II alpha genes in miniature swine
44. Analysis of polymorphism in porcine MHC class I genes: Alterations in signals recognized by human cytotoxic lymphocytes
45. Peripheral tolerance to class I mismatched renal allografts in miniature swine: Donor antigen-activated peripheral blood lymphocytes from tolerant swine inhibit antidonor CTL reactivity
46. T-cell regulation of T-cell responses to antigen
47. Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. II. Sequential changes in alloreactivity of T cell subsets
48. + T cells
49. Suppressor T cells in rats with prolonged cardiac allograft survival after treatment with cyclosporine
50. Th1 and Th2 cells: Different patterns of lymphokine secretion lead to different functional properties